T3D Therapeutics, Inc.

Jul 25, 2024

Leading Alzheimer's Expert Joins T3D Therapeutics' Scientific Advisory Board

Jul 24, 2024

A Novel Way to Reduce Alzheimer's Amyloid Plaque Burden, Phase 2 Clinical Trial Results of T3D-959 to be Presented by T3D Therapeutics at AAIC

Aug 27, 2020

T3D Therapeutics Receives a Research Award from the Alzheimer's Association Part the Cloud-Gates Partnership Grant Program